Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024

Rhea-AI Summary

Veracyte (Nasdaq: VCYT) has announced that it will release its second quarter 2024 financial results after market close on Tuesday, August 6, 2024. The company will host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to discuss the results and provide a general business update. Investors and interested parties can access the live webcast from Veracyte's website or via a provided link. A webcast replay will be available after the broadcast on the company's investor relations page. For those who prefer to join by phone, dial-in registration is available through a separate link.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the second quarter of 2024 after the close of market on Tuesday, August 6, 2024. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m. Eastern Time on the same day.

The conference call will be webcast live from the company’s website and will be available via the following link: https://edge.media-server.com/mmc/p/p5tuszv4. A webcast replay will be available following the conclusion of the live broadcast and will be accessible on the company’s website at https://investor.veracyte.com/events-presentations.

The conference call dial-ins can be accessed by registering at: https://register.vevent.com/register/BIbb7f6b70b4ce4820b6391059390d6139

About Veracyte

Veracyte (Nasdaq: VCYT) is a global diagnostics company whose vision is to transform cancer care for patients all over the world. We empower clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our Veracyte Diagnostics Platform delivers high-performing cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine, which ultimately drives durable reimbursement and guideline inclusion for our tests, along with new insights to support continued innovation and pipeline development. For more information, please visit www.veracyte.com or follow us on LinkedIn or X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240717602722/en/

Investors:

Shayla Gorman

investors@veracyte.com

(619) 393-1545

Media:

Tracy Morris

media@veracyte.com

(650) 380-4413

Source: Veracyte, Inc.

FAQ

When will Veracyte (VCYT) release its Q2 2024 financial results?

Veracyte (VCYT) will release its second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024.

What time is Veracyte's (VCYT) Q2 2024 earnings call scheduled for?

Veracyte's (VCYT) Q2 2024 earnings conference call and webcast is scheduled for 4:30 p.m. Eastern Time on Tuesday, August 6, 2024.

How can investors access Veracyte's (VCYT) Q2 2024 earnings call?

Investors can access Veracyte's (VCYT) Q2 2024 earnings call via a live webcast from the company's website, a provided link, or by registering for the conference call dial-in.

Will there be a replay available for Veracyte's (VCYT) Q2 2024 earnings call?

Yes, a webcast replay of Veracyte's (VCYT) Q2 2024 earnings call will be available on the company's investor relations website after the live broadcast concludes.